by Sowmya Viswanathan | Sep 6, 2018
In this month’s installment of the “Bioprocess and Bioanalytics” blog, we will hear from Drs. Robin Turner and James Piret on how an established spectroscopy method – Raman spectroscopy – can be utilized to tell us new information about cell therapy products. Both are...
by Jovana Drinjakovic | Aug 29, 2018
Flying a small plane may be easy to learn. Flying a jumbo jet safely, with hundreds of people’s lives in your hands, takes decades of training and testing. Cell and gene therapy today is a bit like a rookie pilot: it will still be some time of carefully monitored...
by Stacey Johnson | Aug 29, 2018
By what measure do we determine whether an industry “has arrived?” Goldman Sachs issued a report in 2017 with a section titled “The Coming Age of Regenerative Medicine” and media were quick to report this. A Business Insider headline stated that “money is pouring in...
by Samantha Payne | Aug 29, 2018
This blog is part of the third annual Signals blog carnival, in which multiple bloggers write about one topic that are then posted simultaneously, exposing readers to a variety of perspectives on a single topic in a unique and interesting format. You can read about...
by Carmen Wong | Aug 23, 2018
Artificial intelligence (AI). Machine learning. To most people, these are just buzzwords and synonymous. Whether or not we fully understand what both are, they are slowly integrating into our everyday lives. Virtual assistants such as Siri? AI is at work. The...
by Samantha Yammine | Aug 15, 2018
You’ve heard the rumours – it is notoriously difficult to get a job as a tenure-track Principal Investigator (PI). The 10,000 PhDs project reported that, on average, about 23 percent of life sciences PhDs from the University of Toronto get a tenure stream position. An...
by Stacey Johnson | Aug 1, 2018
Two years ago in August, Signals hosted a blog carnival and it was such a success we’ve been doing it ever since. If you are scratching your head at the term “blog carnival” and wondering if this website has been hacked, I recommend you read the section below....
by Sara M. Nolte | Jul 30, 2018
I honestly believe that we’re living in the most exciting time for cancer therapeutics. The past few years (dare I say decades, even?) have pushed the boundaries of cancer treatment from radiation and chemotherapy to the use of cancer-targeted antibodies, oncolytic...
Comments